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Characterization of RT6-Bearing Rat Lymphocytes.
II. Developmental Relationships of RT6--and RT6+T Cells
CHRISTOPHER F. MOJCIK’, DALE L. GREINER" and IRVING GOLDSCHNEIDER*"
tDepartment of Pathology, School ofMedicine, University of Connecticut Health Center, Farmington, Connecticut 06030
The derivation of RT6 T cells from postthymic RT6- T cells in weanling rats was formally
demonstrated by the intravenous transfer ("parking") of highly purified populations of RT6-
lymph node T cells into thymectomized, irradiated, and bone-marrow-reconstituted (TXBM)
RT6 and RT7 alloantigen-disparate recipients. Parallel experiments in irradiated and bone-
marrow-reconstituted rats, and in rats whose RT6 T cells had been depleted by injection of
DS4.23 anti-RT6.1 mAb, suggested that the transit time between the pre-RT6 and the RT6
T-cell compartments approximated 4-5 days. A more precise estimate of the transit time was
made by linear regression analysis of the generation of RT6 T cells in rats that were treated
with DS4.23 mAb at timed intervals after thymectomy. This study indicated that 50% of the
pre-RT6 T cells differentiated into RT6
/ cells within 4 days, 75% within 8 days, and more
than 90% within 16 days.
Despite the apparent absence of pre-RT6- T cells 3 weeks after thymectomy, numerous
RT6- T cells persisted for at least 10 weeks in thymectomized rats, even after treatment with
DS4.23 mAb. Moreover, these RT6 T cells failed to generate RT6 T cells after transfer into
adoptive hosts. Quantitative and phenotypic analyses indicated that this population of "true"
RT6- T cells: (1) constitutes approximately 50% of the total RT6- T cells normally found in
control rats; (2) contains CD4 and CD8 subsets; (3) expresses both the CD5 pan-T-cell
antigen (which is absent from NK cells) and the R73 cz//J TCR constant-region determinant;
and (4) lacks sIgM.
Hence, the present results indicate that the "true" RT6- and the RT6 T-cell subsets have
stable antigenic phenotypes and represent developmentally discrete populations of post-
thymic cells in normal rats. This is supported by associated phenotypic and functional
studies that suggest that the "true" RT6-T-cell subset contains antigenically naive and/or
autoreactive clonotypes, whereas the RT6 T-cell subset contains memory and/or regulatory
cells. It remains to be determined whether the "true" RT6- and the RT6 subsets represent
separate lineages of T cells or a single lineage at different stages of activation or maturation.
KEYWORDS: Rat T-cell development, T-cell subsets, RT6 and RT7 alloantigens, differentiation antigens, monoclonal antibodies.
INTRODUCTION
RT6 is a low-molecular-weight cell-surface protein
that exists in two known allelic forms and is dis-
played exclusively by members of the T-lymphocyte
lineage in the rat (Lubaroff et al., 1979; Greiner et
al., 1982; Thiele et al., 1987; Mojcik et al., 1988).
Both the RT6.1 and RT6.2 alloantigens are attached
to the cell-surface membrane by phospha-
tidylinositol linkages (Koch et al., 1986; Koch et al.,
1988), however, the RT6.1 alloantigen is glyco-
sylated, whereas the RT6.2 alloantigen is not.
*Corresponding author.
Approximately 70% of peripheral T cells,
including both CD4
/ and CD8
/ subsets, express
RT6, but no RT6 + thymocytes have been detected
(Mojcik et al., 1988). Some RT6
/ T cells, their
precursors, and/or their progeny respond to mito-
genic and allogeneic stimulation, in vitro, secrete
interleukin-2, and participate in the graft-vs.-host
(Greiner et al., 1982; Hunt and Lubaroff, 1985) and
delayed-type hypersensitivity reactions in vivo (Ernst
and Lubaroff, 1984). Furthermore, RT6/T cells have
been shown to play an important regulatory role in
suppressing mixed lymphocyte reactivity in vitro
(Hunt and Lubaroff, 1985) and in preventing auto-
immunity in the spontaneously hyperglycemic BB/
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Wor rat (Greiner et al., 1987), as well as in normal
rats (McKeever et al., 1990). In contrast, at least
some RT6-T cells may serve as autoreactive effector
cells in the absence of RT6
/ T cells (Greiner et al.,
1986; McKeever et al., 1990).
Previously, we have shown that the appearance of
RT6
/ T cells occurs later in ontogeny than does that
of RT6- T cells, and does not reach maximal levels
until 6-8 weeks of age (Mojcik et al., 1988). Intra-
thymic adoptive transfer studies demonstrated that
most, if not all, RT6
/ T cells are thymus-derived;
and neonatal thymectomy experiments provided
suggestive evidence for a parent-progeny
relationship between RT6- and RT6
/ T cells.
Definitive evidence for such a relationship is pro-
vided in the present study using purified subsets of
RT6- and RT6
/ T cells. These RT6- precursors of
RT6
/ cells are referred to as "pre-RT6
/" T cells. In
addition, our results suggest that another population
of RT6- T cells exists that does not contain the pre-
cursors of RT6
/ T cells. We have termed these
lymphocytes "true RT6-" T cells, and have postu-
lated that they may represent a developmentally dis-
crete population of postthymic lymphocytes with
unique functional attributes.
RESULTS
Parent-Progeny Relationship of RT6- and RT6+
T Cells
a. Adoptive transfer studies. To investigate formally
the developmental relationships of RT6-and RT6
/
T-cell subsets, purified populations of RT6- and
RT6
/ lymph-node T cells from BUF rats were
injected i.v. into histocompatible TXBM M520 recipi-
ents. Donor-origin RT6- and RT6
/ T cells in spleen
and lymph node were quantified 6 weeks later by
double immunofluorescence analysis for the RT6.1
(T-cell subset) and RT7.2 (pan-T-cell) alloantigens.
As shown in Table 1, normal percentages
(approximately 70%) of RT6
/ donor-origin T cells
were observed in adoptive recipients of either
unfractionated lymph-node T cells or purified
(> 98%) RT6- T cells obtained from nonthymecto-
mized rats. In contrast, when purified populations of
RT6
/ T cells were adoptively transferred, only RT6
/
donor-origin T cells were detected in the recipients.
As anticipated (Greiner et al., 1982; Mojcik et al.,
1988), no donor-origin RT6
/ or RT6-T cells whatso-
ever appeared in TXBM recipients of BUF bone
marrow cells (data not shown).
Conversion of the results to whole-body T cells
(Rossini et al., 1986) by the method of Everett et al.
(1964), showed that at 6 weeks after cell transfer,
the total number of donor-origin T cells in the
recipients of either unfractionated, purified RT6-, .or
purified RT6
/ T cells closely approximated the
number of T cells in the original inoculum (Table 1).
Moreover, 16.8x106 (84%) of the 20x106 donor-
origin T cells present in the recipients of purified
RT6-T cells were RT6 /.
b. Transit time between the pre-RT6 and RT6
/ T-Cell
compartments. Previous ontogenetic studies had
suggested that 4 days was the minimal interval
required between the release of RT6- T cells from
the thymus and the expression of the RT6 antigen
on their surface (Mojcik et al., 1988). To gain further
information about the kinetics of differentiation,
bone marrow cells from young adult BUF rats were
injected i.v. into irradiated (750 rad) M520 recipients
and the appearance of donor-origin (RT7.2 /) RT6
/
and RT6-T cells was determined. As shown in.Fig.
1, donor-origin RT6-T cells were first detected in
both spleen and lymph node on day 25, whereas
donor-origin RT6/ T cells were first detected in
these tissues on day 30. Total and RT6
/ donor-origin
T cells increased rapidly and in parallel thereafter,
and began to plateau at 6-8 weeks. As in normal
ontogeny (Mojcik et al., 1988), the relative propor-
tion of T cells that expressed RT6 increased pro-
gressively during the second month after bone-
marrow-cell transfer, and reached stable adult levels
(approximately 70%) within 3 months. In addition,
both OX8
/ (CD8) and W3/25
/ (CD4) subsets of RT6
/
T cells were generated with kinetics similar to those
observed during normal ontogeny (Mojcik et al.,
1988; data not shown).
In a second series of experiments in young adult
LEW rats, RT6
/ T cells were depleted (> 99%) by a
single i.v. injection of DS4.23 (anti-RT6.1) mAb (see
Materials and Methods). As shown in Table 2,
although many T cells (RT7 /) remained in spleen
and lymph node at 24 hr, RT6
/ T cells were not
detected until day 5 after DS4.24 treatment. There-
after, the percentage of total T cells that expressed
RT6 increased progressively to reach approximately
70% of control levels in spleen and lymph node by
day 21.
To control for the possible effects that the con-
tinued release of RT6-T cells from the thymus may
have had on the pool of pre-RT6
/ T cells and/or
their rate of differentiation into RT6
/ T cells, youngRT6- AND RT6 RAT T CELLS 193
TABLE 1
Ability of RT6 and RT6- T-Cell Subsets from BUF Rat Lymph Node. to Repopulate the T-Cell Compartments of TXBM M520 Rats
BUF T-cell innoculum Recovery of donor-origin T cells in M520 recipients
Donor RT7.2 T cells Donor RT6.1 T cells
T-cell No. cells % RT6 % in Total Total % in Total Total % RT6+/RT7
subset injected T cells Organ organ in organ in body organ in organ, in body
xl0-) xl0-) xl0-) xl0-)
Total T cells 23 52.4 LN 14.4 +_ 1.7 ND ND 10.0 + 2.7 ND ND 69.4
Spl 8.4 -t- 2.7 9.2 23.0 5.8 _+ 3.4 6.3 15.6 69.1
Total RT6 25 94.5 LN 5.6 -t- 3.7 ND ND 5.6 -t- 3.7 ND ND 100.0
Spl 4.4 -t- 1.4 8.4 21.0 4.4 -t- 1.4 8.4 21.0 100.0
Total RT6- 22 2.0 LN 11.1 -I- 7.8 ND ND 7.2 + 4.2 ND ND 64.9
Spl 6.0 -t- 2.2 8.0 20.0 5.0 -t- 1.8 6.7 16.8 83.3
"True" RT6- 24 1.3 LN 8.4 ND ND "0.4 ND ND 4.8
Spl 3.6 + 0.3 4.0 10.0 0.4 +- 1.3 0.4 1.0 10.0
aThymectomized, irradiated, and syngeneic bone-marrow-reconstituted (TXBM) adult M520 (RT6.2, RT7.1) rats were injected with one of the following
BUF (RT6.1, RT7.2) rat lymph-node T-cell populations: Total (unfractionated) T cells enriched by nylon wool passage; RT6 T cells enriched by "panning"
using F(Ab’)2 DS4.23 (anti-RT6.1) mAb; total RT6- T cells obtained 24 hr after treatment of normal rats with intact DS4.23 (anti-RT6.1) mAb; or "true" RT6-
T cells obtained from rats thymectomized 4 weeks before treatment with intact DS4.23 mAb (see Materials and Methods). Six weeks after adoptive
transfer, recipients were analyzed for donor origin RT7.2 and RT6.1 T cells by flow cytofluorimetry. Results represent the mean + S.D. of three to four
animals per group or were obtained from pooled tissues of three to four animals. ND: not determined.
bTotal donor-origin RT7 and RT6 cells in the body were calculated by the method of Everett et al. (1964), assuming spleen contains 40% of total body
T lymphocytes.
adult LEW rats were injected with DS4.23 mAb at
different times after thymectomy. These rats were
then analyzed for RT6
/ T cells 2 weeks after cessa-
tion of mAb treatment. In order to be certain that all
70
RT6
/ T cells were destroyed, DS4.23 mAb was
administered on two alternate days.
Results in Table 3 show that injection of DS4.23
mAb between days 3 and 15 after thymectomy cause
a progressive decrease in the number of spleen cells
that became RT6/; and no RT6
/ T cells were
generated within 2 weeks by rats that received
DS4.23 mAb on day 21 after thymectomy. Moreover,
regression analysis of the decrease in the number, of
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FIGURE 1. Kinetics of appearance of
donor-origin RT7 (total) (solid line)
or RT6 (dashed line) T cells in lymph
node (@, O) and spleen (., r’]) of
histocompatible, RT6- and RT7-
disparate M520 rats with time after
750 R irradiation and adoptive
transfer of BUF bone marrow cells i.v.
Each point represents the mean of
three to six recipients, as determined
by flow cytofluorimetry.194 C. F. MOJCIK, D. L. GREINER AND I. GOLDSCHNEIDER
TABLE 2
Kinetics of Reappearance of RT6.1 T Cells in Nonthymectomized LEW Rats Following Injection of DS4.23 (anti-RT6.1) mAb
Percentage of positive cells
Days after Spleen Lymph node
injection of
DS4.23 mAb RT6.1 RT7.1 RT6//RT7 RT6.1 RT7.1 RT6+/RT7
1 <1 39.9+/-0.6 0.0 <1 50.9+/-2.9 0.0
3 <1 ND ND <1 ND ND
5 8.9 ND ND 4.7 ND ND
7 14.4+/-1.9 38.9+/-1.9 37.0 23.5+/-3.0 54.9+/-3.9 42.8
21 22.3+/-2.4 46.2+/-2.5 48.3 27.1+/-6.5 56.7+/-6.4 47.8
Control 34.7+/-3.7 60.1+/-6.1 57.7 46.9+/-1.3 70.2+/-2.8 66.8
aEach rat received a single i.v. injection of 0.3 mg/kg DS4.23 (anti-RT6.1) mAb. Results represent the mean+/- S.D. of three to six animals per group, as
determined by flow cytofluorimetry. Cells from day 5 were pooled from four rats prior to analysis. Control is age-matched for the day 21 time point.
bThe total number of RT7.1 T cells was decreased by 59.2% in spleen and 67.6% in lymph node.
*ND: not determined.
RT6
/ cells as a function of increasing time between
thymectomy and the administration of DS4.23 mAb
(Fig. 2) shows that: (1) it was strictly linear
(r2=0.99) through day 12; (2) 50% of the pre-RT6
cells passed from the RT6-- to the RT6/-cell com-
partment in approximately 4 days; and (3) the base-
line (no detectable RT6
/ cells) was intercepted at
day 16.
TABLE 3
Kinetics of Reappearance of RT6.1 T cells in the Spleen of LEW
Rats Following the Injection of Anti-RT6.1 (DS4.23) mAb at
Various Times after Thymectomy
Days after thymectomy Number of RT6
on which DS4.23 mAb cells in spleen
was injected 2 weeks later
xl0 -)
No Antibody 16.0 +/- 3.2
1 and 3 10.1 +/- 4.5
4 and 6 5.2 +/- 2.9
7 and 9 3.7 +/- 0.6
10 and 12 1.8 +/- 0.6
13 and 15 <
16 and 18 <
19 and 21 < 1
aWeanling LEW rats were thymectomized and injected with DS4.23
mAb (anti-RT6.1) mAb (0.3 mg/kg body weight) on the indicated days
following thymectomy. Rats were sacrificed weeks after the second injec-
tion. Results represent mean +/- S.D. of three to four animals per group, as
determined by flow cytofluorimetry.
bSee Fig. 2 for the linear regression analysis of data.
Evidence for a Separate Population of "True"
RT6- T Cells
The results of the preceding study indicated that
rats thymectomized approximately 2.5 weeks pre-
viously lack pre-RT6
/ T cells. Yet previous obser-
vations (Mojcik et al., 1988) demonstrated that sub-
stantial numbers of splenic RT6-T cells remained 6
and 10 weeks after thymectomy. This suggested that
not all RT6- T cells are pre-RT6
/ T cells.
To test this hypothesis, young adult LEW rats
were thymectomized, treated with DS4.23 mAb 4
weeks later, and assayed for RT6
/ T cells in the
spleen 6 weeks thereafter. Results in Table 4 show
that only 8.1% of the total T ceils were RT6
/ in the
thymectomized, DS4.23-injected animals, whereas
approximately 59%, 67%, and 40% of the T cells
were RT6 + in control rats that were sham-thymecto-
mized, thymectomized only, or DS4.23-injected
only, respectively. Yet the thymectomized, DS4.23-
injected rats contained approximately 62% and 50%
of the total number of RT6-T cells as did the sham-
thymectomized and DS4.23-injected controU rats.
Moreover, despite the major difference in the
number of RT6
/ T cells (1.5 x106 vs. 21.6 X106) in the
thymectomized, DS4.23-injected and the thymecto-
mized, non-DS4.23-injected rats, there was no
difference between the number of RT6-T cells in
these two groups of rats (15.8 x106 vs. 10.9 X106).
Similar results were obtained in a group of LEW
rats that were treated with DS4.23 mAb 4 weeks
after thymectomy and assayed for RT6
/ spleen cells
3 weeks (instead of 6 weeks) later. Only 4.1%
(0.5X106) of the RT7 + T cells were RT6 + in the
thymectomized, DS4.23-injected rats, as compared
to 48.2% (23.9x106) in the sham-thymectomized,
DS4.23-injected control rats. Again the thymecto-
mized, DS4.23-injected rats contained approximately
50% of the total number of RT6- T cells as did the
sham-thymectomized, DS4.23-injected controls (data
not shown).
To demonstrate further that not all RT6-T cells
are the precursors of RT6
/ T cells, purified popula-RT6-AND RT6 RAT T CELLS 195
tions of RT6- lymph-node T cells, obtained from
BUF rats thymectomized 4 weeks prior to treatment
with DS4.23 mAb, were adoptively transferred into
TXBM M520 recipients. Results in Table I (bottom
line) show that less than 10% of the donor-origin T
cells expressed RT6 antigen 6 weeks later, and that
the total number of RT6-T cells that remained was
approximately half of the number that was originally
transferred. This is in marked contrast to results
obtained after the transfer of purified RT6-T cells
from nonthymectomized donors, in which 83% of
the donor-origin T cells exPressed RT6 antigen 6
weeks-later and the total number of T cells
recovered approximated the total number of T cells
transferred.
Antigenic Phenotypes of "True" RT6- T Cells
The antigenic phenotypes of the lymphoid cells in
spleen and lymph node of LEW rats was determined
1-
0 4 8 12
e\
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4 weeks after thymectomy. T cells were identified by
the expression of the RT7.1 alloantigen and the R73
TCR framework antigen; B cells by the expression of
slg. Results in Table 5 show that the percentage of T
cells decreased moderately in the thymectomized
rats as compared to sham-thymectomized controls,
and that this decrease was accompanied by a com-
pensatory increase in the percentage of sIg
/ B cells:
In addition, the percentage of RT6
/ T cells and the
CD4 (W3/25):CD8 (OX8) ratios (2.6:1) in the
thymectomized rats were not significantly different
than control values.
In contrast, the percentage of T cells was
markedly decreased in rats that were injected with
DS4.23 (anti-RT6.1) mAb 4 weeks after thymectomy;
and the percentage of RT6
/ cells was reduced from
29% to 0% and from 49% to 1% in spleen and
lymph node, respectively. Nonetheless, the
CD4:CD8 ratio was normal or slightly elevated in
the thymectomized (and sham-thymectomized),
DS4.23-treated rats; and, as shown in Table 6,
normal percentages of T cells expressed the OX19
(CD5) and R73 (c//J TCR) antigens.
Lastly, the results of Table 7 show that the
number of total (RT7 /) T cells decreased 42% and
the number of RT6
/ and RT6-T cells decreased 35
and 50%, respectively, in the spleens from the rats
thymectomized 4 weeks previously. In contrast, the
number of total T cells decreased 73% in the rats
that were injected with DS4.23 mAb 4 weeks after
thymectomy, reflecting the complete elimination of
residual RT6
/ T cells. As anticipated, the number of
RT6- T cells in both thymectomized and sham-
thymectomized rats was unaffected by treatment
with DS4.23 mAb; and the number of splenic B cells
was unaffected by either thymectomy and/or DS4.23
mAb treatment.
FIGURE 2. Linear regression analysis (r =0.99)
of the reappearance of RT6.1 T cells in the
spleen of LEW rats 2 weeks after their depletion
by the injection of DS4.23 (antioRT6.1) mAb at
indicated times after, thymectomy (see footnote
from Table 3 for details). Intercept of ordinate
indicates number of RT6 T cells in thymec-
tomized but non-DS4.23-treated control rats.
Intercept at abscissa (dashed line) indicates pro-
jected day after thymectomy after which no
detectable RT6 T cells are regenerated. Arrow
designates approximate time after thymectomy
during which 50% of the total RT6 T cells are
regenerated by RT6- precursors.196 C. F. MOJCIK, D. L. GREINER AND I. GOLDSCHNEIDER
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TABLE 4
Frequency of RT6 T Cells in Spleen of Thymectomized LEW Rats Six Weeks after Treatment with Anti-RT6.1 (DS4.23) mAb
Treatment
of rats % Positive T cells No. positive T cells xl0 -6)
DS4.23 RT7 RT6 RT6//RT7 RT7 RT6 RT6-
31.6 + 6.1 23.3 + 2.9 59.2 68.1 + 4.4 47.4 + 13.4 25.6 + 8.2
+ 25.5 +/- 6.4 17.2 +/- 1.7 67.5 31.0 +/- 9.7 21.6 +/- 8.8 10.9 +/- 2.9
+ 37.2 +/- 1.3 14.7 +/- 1.6 39.5 53.8 +/- 7.0 21.7 +/- 2.1 32.1 +/- 7.1
+ + 21.1 +/- 4.2 1.7 +/- 1.1 8.1 17.3 +/- 6.5 1.5+ 1.0 15.8 4- 5.8
aWeanling LEW rats were thymectomized, treated with 0.3 mg/kg DS4.23 mAb 4 weeks later, and sacrificed 6 weeks thereafter (10 weeks total .elasped
time since thymectomy). Age-matched control rats were either sham-thymectomized and injected with buffer, thymectomized only, or treated with DS4.23
mAb only. Harvested nucleated spleen cells were analyzed for RT7.1 and RT6.1 antigens by flow microfluorimetry. Results represent the mean _+ S.D. of
four to six animals per group.
TABLE 5
Antigenic Phenotypes of Lymphocytes in Thymectomized and/or Anti-RT6.1 (DS4.23) mAb-Treated LEW Rats
Treatment
of rats % Positive lymphocytes
Tx DS4.23 Tissue R73 RT7.1 RT6.1 RT6.1/RT7.1 W3/25 OX8 sIg
Spl 66.2 +/- 2.3 56.2 +/- 0.5 29.1 +/- 0.8 51.8 50.6 +/- 0.7 21.8 4-1.4 33.4 + 0.8
+ Spl 49.9 +/- 2.7 45.0 +/- 2.2 26.3 +/- 1.3 58.4 43.7 + 0.7 16.8 + 1.5 40.8 +/- 2.0
+ Spl ND 40.3 +/- 2.3 0.0 + 0.0 0.0 38.0 +/- 4.1 15.3 +/- 1.7 ,49.3 + 2.1
+ + Spl 18.7 +/- 2.1 23.0 +/- 2.8 0.0 +/- 0.0 0.0 24.0 +/- 1.6 10:1 +/- 0.8 60.2 +/- 2.5
LN 68.3 +/- 2.7 48.9 +/- 2.7 71.6 58.2 +/- 2.9 22.3 + 0.7 26.3 +/- 3.0
+ LN 44.7 +/- 0.8 36.2 +/- 1.4 81.0 43.3 +/- 3.4 17.0 +/- 1.2 49.1 4- 0.6
+ LN 42.8 +/- 9.0 1.6 +/- 1.5 3.7 46.6 +/- 2.3 12.2 +/- 2.2 57.4 +/- 0.9
+ + LN 19.4 4- 3.7 1.0 +/- 0.6 5.2 24.0 4-1.9 6.2 +/- 1.0 68.2 4- 5.1
aWeanling LEW rats were thymectomized, treated with 0.3 mg/kg DS4.23 mAb 4 weeks later, and sacrificed 24 hr thereafter. Age-matched control rats
were either sham-thymectomized and injected with buffer, thymectomized only, or treated with DS4.23 mAb only. The antigenic phenotypes of the
nucleated spleen (Spl) and lymph-node (LN) cells were determined by flow microfluorimetry. Results represent the mean+/- S.D. of three animals per
group. ND: not determined.
DISCUSSION
In a previous report (Mojcik et al., 1988), we
demonstrated that the expression of the RT6 allo-
antigen on a subset of T cells is a postthymic
maturational event, and we provided indirect evi-
dence that RT6
/ T cells are derived from RT6- T
cells (i.e., "pre-RT6/" T cells). We also suggested
that a second population of RT6-T cells may exist,
one that does not generate RT6/T cells (i.e., "true
RT6-" T cells). The results of the present study
strongly support the existence of both pre-RT6
/ and
true RT6-T-cell subsets.
Adoptive transfer ("parking") experiments in
TXBM rats showed that normal proportions of RT6 +
T cells are generated within 6 weeks by purified
populations of RT6- T cells obtained from
TABLE 6
Expression of OX19 (CD5) and RT7 (TCR) Antigens by T Lympho-
cytes in Spleen Of Thymect0mized (TX) and/or Anti-RT6.1
(DS4.23) mAb-Treated LEW Rats
Treatment of rats % of T lymphocytes (RT7+) that express
Tx DS4.23 OX19 R73
78.4+/-3.8 87.0+/-2.1
+ 77.6 + 3.4 83.9 +/- 1.2
+ 78.1 +/- 2.6 ND
+ + 71.7 4- 2.4 70.6 +/- 7.7
’See footnote from Table 5 for treatment of rats., The percentage of
doubly labeled cells was determined by two-color fluorescence microscopy.
Results represent the mean+/-S.D, of three animals per group. ND: not
determined.
nonthymectomized donors, and that the expression
of the RT6 antigen is not dependent upon the con-
tinued presence of a thymus. The demonstration
that TXBM recipients of purified RT6
/ T cells con-RT6- AND RT6 RAT T CELLS 197
tained only RT6
/ T cells 6 weeks later strongly sug-
gests that the differentiation of RT6
/ T cells from
RT6-precursors is unidirectional. This does not
exclude the possibility, however, that activated RT6
/
T cells might transiently fail to express the RT6
antigen, as suggested by Hunt and Lubaroff (1987),
or that some RT6/T cells might themselves generate
additional RT6
/ T cells.
Studies of the sequential appearance of RT6- and
RT6
/ T cells in irradiated and BM-reconstituted
adult rats and in rats whose RT6
/ T cells had been
ablated by treatment with the DS4.23 mAb
suggested that the minimum transit time between
the pre-RT6
/ and RT6 + T-cell compartments was 4-5
days. Similar kinetics have been observed during
normal ontogeny (Mojcik et al., 1988). However,
given the continued contribution of the thymus to
the peripheral T-cell pool in the preceding experi-
ments, other explanations for the delayed appear-
ance of RT6
/ cells are possible, such as the existence
of separate precursor-cell populations for RT6- and
RT6
/ T cells, each having different generative
kinetics. Therefore, it is significant that experiments
in thymectomized and DS4.23 mAb-treated adult
rats not only confirmed the presence of pre-RT6
/ T
cells, but identified a developmentally unrelated (or
more primitive) population of true RT6-T cells.
In these latter experiments, the population of pre-
RT6
/ T cells decreased exponentially with time after
thymectom, such that 50% of the precursor activity
was absent by four days, 90% by 12 days, and vir-
tually all by 21 days (see Table 3). Yet, despite the
apparent absence of pre-RT6
/ cells, approximately
50% of the original number of RT6-T cells were
present 4 weeks after thymectomy (see Table 7).
Similarly, at 10 weeks, the number of RT6- T cells
that were recovered from the spleens of thymecto-
mized and DS4.23 mAb-treated rats was approxi-
mately 50% of that recovered from nonthymecto-
mized, DS4.23-treated controls (see Table 4). Equi-
valent results were obtained by comparing the
residual numbers of donor-origin RT6-T cells in
TXBM recipients of purified RT6- T cells from
normal and thymectomized rats (see Table 1).
Hence, it appears that, under steady-state conditions
in nonthymectomized rats, approximately half of the
RT6- T cells are true RT6- T cells.
Although it is possible that some RT6-T cells
may require more than 4 weeks to express the RT6
antigen, it is unlikely that this applies to the vast
majority of the RT6- T cells in thymectomized rats.
Thus, we have observed that such rats maintain
normal ratios (albeit decreasing numbers) of RT6-
and RT6
/ T cells for at least an additional 2-6 weeks
after thymectomy (Mojcik et al., 1988; see also
Results and Table 4); and that diabetes-prone BB
rats continue to lack RT6 + T cells at 1 year of age
(M. Angelillo, unpublished observation), despite
having normal numbers of RT6-T cells (Greiner et
al., 1986), a functional thymus (Angelillo et al.,
1988), and a functional RT6 gene (Angelillo et al.,
1988).
Because the RT7 alloantigenic marker not only is
expressed by T cells in the rat (Lubaroff, 1973;
Greiner et al., 1982), but also by B cells (Mojcik et
al., 1987) and NK cells (Reynolds et al., 1981), it was
important to confirm that the RT7
/ RT6- cells in
thymectomized rats were in fact T cells. This was
done in three ways. First, we used a titer of anti-
RT7.1 mAb that reacts with T cells but not detec-
tably with B cells (Mojcik et al., 1987) to stain the
RT6-lymphocytes (see Table 5). Second, we
demonstrated that the OX19 (CD5) pan-T-cell
antigen, which is absent from NK cells (Reynolds et
TABLE 7
Number.( xl0-) of RT6 and RT6- T Cells and sIg B Cells ir Spleen of Thymectomized and/or Anti-RT6.1 (DS4.23) mAb-Treated LEW
Rats
Treatment of rats T cells B cells
Tx DS4.23 RT7 RT6 RT6- sIg
189.6 + 25.0 98.5 + 15.0 91.1 + 10.1 112.4 + 12.9
+ 111.1 + 23.6 64.3 + 9.7 46.8 + 14.8 99.1 + 11.7
+ 91.2 + 10.2 0.0 + 0.0 91.2 + 10.2 111.5 + 11.7
+ + 50.6 + 6.1 0.0 + 0.0 50.6 + 6.1 122.7 + 17.2
aSee footnote from Table 5 for treatment of rats. The numbers of RT7 and RT6 T cells and slg B cells were determined by multiplying the percentage
of cells that expressed these antigens by the total number of nucleated spleen cells per animal. The number of RT6- T cells was calculated by subtracting
the number of RT6 cells from the number of RT7 cells in the spleen of each animal. Results represent the mean (xl0-") + S.D. of three animals per
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al., 1981; Mason et al., 1983), was expressed by
approximately 70% of the RT6- RT7
/ spleen cells
(see Table 6). Third, we demonstrated that approxi-
mately 70% of the RT6- RT7
/ spleen cells expressed
the recently described R73 a/ TCR framework
antigen (Hunig et al., 1989).
Additional phenotypic analyses indicated that the
population of true RT6-T cells contains both W3/
25
/ (CD4) and OX8
/ (CD8) subsets. The fact that
the sum of the percentages of the W3/25
/ and OX8
/
cells in Table 5 exceeds that of total T cells (RT7 /,
R73 /) probably reflects the expression of W3/25 by
macrophages as well as by T cells (Jeffries et al.,
1985). Thus, by computing the RT7:OX8 ratio
instead of the W3/25:OX8 ratio, it can be seen that
the representation of CD8
/ cells (and, hence, of
CD4 + cells) among the true RT6-T cells is approxi-
mately equal to that among the total population of T
cells in normal spleen (2.3:1 vs. 2.6:1) and lymph
node (3.1:1 vs 3.1:1).
Although several functional properties have been
attributed to RT6
/ T cells (see Introduction), almost
nothing is known about the functions of RT6-T
cells. Therefore, it is of great interest that the sus-
ceptibility of lymphopenic BB/W strain rats to auto-
immune insulin-dependent diabetes mellitus has
been found to be associated with the congenital ab-
sence of RT6
/ T cells; and that the resistance of
nonlymphopenic BBAN and normal strain rats to
diabetes (and thyroiditis) is associated with the pre-
sence of RT6
/ T cells (Greiner et al., 1986, 1987;
Burnstein et al., 1989; McKeever et al., 1990). These
latter studies not only have confirmed the presence
of immunoregulatory cells within the RT6
/ T-cell
subset, but have demonstrated that the autoreactive
effector T cells (and/or their precursors) reside
within the RT6-T-cell subset. An analogous situa-
tion may also exist in mice, in which there is evi-
dence of a homologue of the rat RT6-differentiation
antigen (Koch et al., 1990), and in which defective
suppressor T-cell activity has been demonstrated in
the NOD stain of diabetic mouse (Serreze and
Leiter, 1988; Boitard et al., 1989).
Recent studies have provided additional support
for. the notion that autoreactive T-cell clonotypes
and regulatory T cells thereto selectively reside
within the RT6-and RT6
/ subsets, respectively.
Chen-Woan and Greiner (1991) have observed that
most of the RT6-T cells in normal rats are strongly
positive for the OX22 differentiation antigen
(CD45R-hi), whereas most of the RT6
/ T cells are
weakly OX22 positive (CD45R-lo). This correlation
may be significant, inasmuch as Powrie and Mason
(1990) have demonstrated that purified CD45R-hi T
cells induce organ-specific autoimmunity in congeni-
tally athymic rats, and that CD45R-lo T cells appear
to inhibit this autoaggressive activity. In addition,
Goldschneider et al. (1991) and Chen-Woan and
Goldschneider (1991) have described the release of
large numbers of potentially autoreactive T cells
from the thymus of Cyclosporine A-treated rats.
These cells had an "immature" T-cell phenotype and
were RT6-.
Hence, both developmental and functional evi-
dence supports the notion that the population of
"true" RT6- T cells is distinct from pre-RT6
/ T cells.
Indeed, the observation that the defective generation
of RT6
/ T cells by BB/W rats can be traced to abnor-
malities in prothymocytes (Angelillo et al., 1988)
raises the possibility that separate progenitors may
exist for RT6
/ and true RT6-T cells.
Therefore, it must be caUtioned, that it still is pos-
sible that "true"-RT6-T cells are very early pre-
cursors of RT6
/ cells (i.e., pre-pre-RT6
/ cells), but
that they require continued thymic influence to pro-
liferate and differentiate into thymus-independent
pre-RT6
/ cells. An even more likely possibility is
that "true" RT6-T cells represent antigenically naive
T cells (including cells that have avoided negative
selection in the thymus), whereas RT6
/ T cells
represent memory T cells. This has been suggested
by studies of the properties of the CD45R-hi and
CD45R-lo CD4
/ T-cell subsets in both the rat
(Powrie and Mason, 1988, 1990; Chen-Woan and
Greiner, 1991) and the mouse (Lee et al., 1990). It
also is consistent with the observations of Haya-
kawa and Hardy (1989), who used the 3Gll mAb to
detect naive (3Gl1/) and memory (3Gll-) subsets of
murine CD4
/ T cells. These cells not only were
thought to have a precursor-progeny relationship,
but appeared to express the functions and lympho-
kine patterns of TH1- and TH2-helper T cells
(Mosman and Coffman, 1989), respectively. More-
over, depending on the nature of the antigenic
stimulus to which it was exposed, the CD4
/ 3Gil-
T-cell subset could be subdivided by the 6C10 mAb
into two phenotypically stable populations (6C10-
and 6C10/), each arising from a 6C10-precursor.
It, therefore, will be important to determine if a
"switch" between the "true" TR6-and the RT6
/ sub-
sets of CD4
/ rat T cells can be induced by appro-
priate antigenic stimulation; and whether either of
these subsets (or subsets thereof) corresponds to the
TH1- or TH2-type of helper T cell. It also will beRT6- AND RT6 RAT T CELLS 199
important to determine if the CD45R-hi subset of Francisco, CA; and an affinity-isolated, FITC-
RT6-T cells is the repository of autoreactive T cells conjugated goat antimouse IgG (heavy- and light-
in normal as well as BB/W rats, and whether such chain specific, rat serum absorbed) was purchased
cells are regulated by the CD45R-lo subset of RT6
/ T from Kirkegaard and Perry Laboratories, Gaithers-
cells. The answer to these questions may provide burg, MD.
important insights into the developmental and func-
tional heterogeneity of the T-cell system, and parti-
cularly into the pathogenesis of certain forms of
organ-specific autoimmune disorders.
MATERIALS AND METHODS
Animals
Preparation of Cell Suspensions
Spleen, cervical lymph node, and thymus single-cell
suspensions were prepared by gently pressing the
tissues through a stainless-steel sieve (50 mesh).
Bone marrow was obtained by flushing the femur
and tibia with cold medium (HEPES buffered RPMI
1640). Red blood cells were removed from spleen
Five-six-week-old rats of the LEW (RT11, RT6.1, and bone-marrow-cell suspensions by hypotonic
RT7.1), M520 (RT1b, RT6.2, RT7.1), and BUF (RT1b, lysis in 0.168M NH4C1. Cell viability was deter-
RT6.1, RT7.2) and WF (RT1u, RT6.2, RT7.2) inbred mined by exclusion of 0.1% trypan blue and was
strains were obtained from the Mammalian Genetics > 95% in all cases.
and Animal Production Section of the National
Cancer Institute, Frederick,. MD. Rats were main- Immunofluorescence Analysis
rained in laminar-flow hoods on commercial rat
chow and acidified chlorinated water (pH 2.2; free Direct and indirect immunofluorescence staining
chlorine 5-10 ppm)ad libitum, was performed as described previously (Mojcik et
al., 1987, 1988). Dual immunofluorescence for the
Antibodies
DS4.23 (RT6.1) and 8G6.1 (RT7.2) mAbs was per-
formed using FITC-conjugated 8G6.1 and biotin-
Hybridoma cell lines secreting the rat mAb to the conjugated DS4.23 developed with TRITC-avidin.
postthymic RT6.1 (DS4.23), RT6.2 (6A5), and the Double labeled cells were analyzed by fluorescence
pan-T cell RT7.1 (BC84) and RT7.2 (8G6.1) allo- microscopy using narrow-band filters for FITC and
antigens are maintained in our laboratory and pre- TRITC. Dual immunofluoresence for the BC84
viously have been characterized (Ely et al., 1983; (RT7.1) and FITC-OX19 or FITC-R73 mAbs was per-
Milford et al., 1983; Mojcik et al., 1987). Fluorescein formed using PE-conjugated goat antirat IgG to
conjugation of the DS4.23, 6A5, BC84, and 8G6.1 develop the BC84. In some experiments, the
mAb was done according to the method of The and intensity of fluorescence of the FITC-R73 mAb was
Feltkamp (1970). Conjugation of biotin to DS4.23 increased by developing with FITC-conjugated goat
was performed according to the method of Bayer antimouse IgG. Cells doubly labeled for FITC and
and Wilcheck (1974). Fluorescein (FITC)-conjugated PE were analyzed by flow microfluorimetry (FACS
OX19 (CDS) mAb was kindly provided by Dr. M. Analyzer, Becton Dickinson and Co., Sunnyvale,
Chen-Woan, Hartford Hospital, Hartford, CT. An CA). Dead cells were excluded electronically, and
FITC-conjugated mouse mAb to the R73 rat alpha/ the fluorescence channels were precalibrated using
beta T-cell antigen-receptor framework (Hunig et al., fluorescent beads. Controls routinely included an
1989) was purchased from Bioproducts for Science, irrelevant primary antibody or omission of the pri-
Inc., Indianapolis, IN. An F(ab’)2 fragment of a mary antibody.
fluorescein (FITC)-conjugated rabbit antirat IgG
(heavy- and light-chain specific) was purchased Separation ofRT6+ and RT6-T Ceils/n vitro
from Cappell Laboratories, Dowington, PA. Cross-
reacting antibodies to mouse Ig were removed by Enriched suspensions of lymph-node T cells were
passage over a mouse Ig Sepharose 4B affinity prepared by passage over nylon wool columns, as
column (Greiner et al., 1987). An affinity-isolated, described (Julius et al., 1973), and were >95%
phycoerythrin (PE)-conjugated goat antirat IgG OX19 + (CD5 +) and 5% sIg + in all cases. The T
(heavy- and light-chain specific, mouse absorbed) cells were then labeled with DS4.23 anti-RT6.1 and
was purchased from Caltag Laboratories, South San separated into RT6 + and RT6- subsets by "panning"200 C. F. MOJCIK, D. L. GREINER AND I. GOLDSCHNEIDER
(Wysocki and Sato, 1978). For this purpose, 10 X10
labeled cells in 3 ml cold RPMI-1640 medium con-
taining 5% gamma-globulin-free horse serum
(GIBCO, Chagrin Falls, OH) were placed in plastic
Petri dishes (# 1001, Falcon, Oxnard, CA) that had
been coated by incubation for 24 hr at 4C with 10
of goat antirat IgG in 5ml PBS. The cells were
allowed to settle in the dishes for 30 min at 4C, the
nonadherent (RT6-) T cells were recovered by
washing in medium with gentle swirling, and the
adherent (RT6 /) T cells were recovered by gently
scraping the plate with a rubber policman after
residual nonadherent cells had been removed by
vigorous swirling of medium. The purity of the RT6-
and RT6
/ T-cell subsets obtained by this procedure
exceeded 95% as determined by immunofluore-
scence. Only F(ab’)2 fragments of anti-RT6.1 and
antirat Ig were used so as to prevent opsonization of
the positively selected RT6.1
/ lymphocytes in adop-
tive transfer studies (Greiner et al., 1982, 1987).
Depletion of RT6+ T cells
In some experiments, intact (as opposed to F(ab’)2
DS4.23 anti-RT6.1 mAb was used to deplete pre-
existing RT6.1
/ T cells in vivo. This mAb has pre-
viously been found to specifically eliminate RT6
/ T
cells, rather than to simply "mask" or modulate the
RT6 antigen from the cell surface (Greiner et al.,
1987; Woda et al., 1988). This was confirmed by
preliminary dose-response experiments in 100-400-g
LEW (RT6.1/) rats. The results showed that injection
of optimal doses of DS4.23 mAb not only completely
depleted RT6
/ cells in spleen and lymph node, but
proportionately decreased the total number of T cells
(RT7.1/) as well (eg see Table 7). As anticipated, the
number of B cells was unaffected. Moreover, in con-
trol experiments, injection of DS4.23 mAb into WF
(RT6.2 /) rats, or injection of 6A5 (anti-RT6.2) mAb
into LEW (RT6.1 /) rats, did not significantly alter
the proportion or number of splenic RT6
/ T cells
detected, thereby demonstrating the alleleic specifi-
city of these mAbs (data not shown).
Based on these and other results (Greiner et al.,
1987), a standard dose of 0.3 mg/kg body weight of
DS4.23 mAb injected i.v. was used to deplete RT6
/
T cells in LEW rats. Enrichment of the unaffected
RT6- T cells from these animals was achieved by
passage over nylon wool columns, as before.
Thymectomy
Thymectomy and sham-thymectomy was performed
on 4-6-week-old rats under open ether-induced
anesthesia as described (Greiner et al., 1982). The
completeness of thymectomy was confirmed by
gross and histological examination at autopsy.
Adoptive Transfer Systems
Details of the i.v. quantitative adoptive transfer
system for prothymocytes have been described pre-
viously (Greiner et al., 1984; Goldschneider et al.,
1986). Briefly, 25x106 bone marrow cells were
injected i.v. via the tail vein into irradiated (750 rad)
histocompatible, RT6 and/or RT7 alloantigen-
disparate recipients. The percentages of donor- and
host-origin thymocytes and T cells in the recipients
were quantified at various times after reconstitution
by flow microfluorometric analysis using the appro-
priate anti-RT6 and anti-RT7 mAbs.
For adoptive transfer experiments designed to
study the developmental potentials of pUrified RT6
/
and RT6-T cells, the recipient rats were thymecto-
mized, irradiated(750 rad) 4 weeks later, and
injected i.v. with 5 X10 syngeneic bone marrow cells
(TXBM rats). Four weeks thereafter, bone marrow
cells or lymph-node T cells obtained from histo-
compatible, RT6- and RT7-disparate donors were
injected i.v. into these recipients and the appearance
of donor-origin RT6
/ and/or RT6- T cells was
observed at timed intervals by dual-
immunofluorescence analysis for the appropriate
RT6 and/or RT7 alloantigens.
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